Acumen Pharmaceuticals (ABOS) Shares Issued (2021 - 2026)
Acumen Pharmaceuticals recorded quarterly Shares Issued of $145000.0 in Q1 2026, up 7150.0% quarter-over-quarter from $2000.0 in Q4 2025, and up 291.89% year-over-year from $37000.0 in Q1 2025.
Acumen Pharmaceuticals' Shares Issued history runs 6 years deep, the most recent figure standing at $145000.0 for Q1 2026.
- In Q1 2026, Shares Issued rose 291.89% year-over-year to $145000.0; the TTM figure through Mar 2026 stood at $147000.0 (up 101.86% YoY), while the FY2025 annual figure was $39000.0, changed N/A from the prior year.
- Shares Issued came in at $145000.0 for Q1 2026 at Acumen Pharmaceuticals, up from $2000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $7.9 million in Q1 2024 to a low of -$7.9 million in Q4 2024.
- A 5-year average of $60700.0 and a median of $37000.0 in 2025 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued sank 100.0% in 2022 and soared 16150.0% in 2023, its largest moves.
- Acumen Pharmaceuticals' Shares Issued stood at $96000.0 in 2022, then soared by 238.54% to $325000.0 in 2023, then slumped by 2542.46% to -$7.9 million in 2024, then jumped by 100.03% to $2000.0 in 2025, then jumped by 7150.0% to $145000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $145000.0, $2000.0, and $37000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 145,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145,000.00 |
| Mar 31, 2026 | 145,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | -7.94 Mn |
| Dec 31, 2024 | -7.94 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Sep 30, 2023 | 325,000.00 |
| Sep 30, 2023 | 325,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | 167.95 Mn |
| Sep 30, 2021 | 167.95 Mn |